Abstract | PURPOSE: METHODS: RESULTS: The patient survival rates at 1, 5, and 10 years were 76%, 70%, and 61%; the retransplantation rate was 11%. The respective graft survival rates were 71%, 63%, and 59%. There were 60 deaths; 48 (81%) occurred in the first year. These first-year deaths were from sepsis (20; 42%), central nervous system problems (5; 11%), intraoperative complications (4; 8%), lymphoproliferative disease (LPD) (2; 4%), rejection (2; 4%), primary nonfunction (2; 4%), and miscellaneous other causes (7; 15%). There were 12 deaths after the first year, from LPD (3; 25%), sepsis (1; 8%), rejection (2; 18%), cancer (1; 9%), secondary hepatic failure (1; 9%), cerebral vascular accident (1; 9%), or pre- or postoperative complications (3; 25%). Compared with the overall survival rate, patients with MLD had a better chance of survival (83%; P <.012) than did those with AS (45%; P < .001). The 5- and 10-year survival rates for patients with BA were 61% and 58%. Over the past 2 years, the survival rate has increased (87% v 72%; P < .05) as early septic deaths have decreased (from 2.6 to 1.0 per year). CONCLUSION:
Liver transplantation is effective treatment for end-stage liver disease. Decreasing the number of early septic deaths has improved the chance of survival, and better diagnosis and treatment of LPD would improve the late survival rate.
|
Authors | W Andrews, J Sommerauer, J Roden, J Andersen, C Conlin, P Moore |
Journal | Journal of pediatric surgery
(J Pediatr Surg)
Vol. 31
Issue 5
Pg. 619-24
(May 1996)
ISSN: 0022-3468 [Print] United States |
PMID | 8861467
(Publication Type: Journal Article)
|
Chemical References |
|
Topics |
- Adolescent
- Alagille Syndrome
(mortality, surgery)
- Biliary Atresia
(mortality, surgery)
- Cause of Death
- Child
- Child, Preschool
- Drug Therapy, Combination
- Female
- Follow-Up Studies
- Humans
- Immunosuppressive Agents
(administration & dosage, adverse effects)
- Infant
- Life Tables
- Liver Failure
(mortality, surgery)
- Liver Function Tests
- Liver Transplantation
(mortality)
- Male
- Postoperative Complications
(mortality)
- Reoperation
- Survival Rate
|